Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks.

Migden, Michael; Loquai, Carmen; Robert, Caroline; Baurain, Jean-François; Squittieri, Nicholas; Arntz, Ramon; Dierlamm, Jörg; Dréno, Brigitte

Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks.

Migden, Michael; Loquai, Carmen; Robert, Caroline; Baurain, Jean-François; Squittieri, Nicholas; Arntz, Ramon; Dierlamm, Jörg; Dréno, Brigitte.

Afiliação

Migden M; Department of Dermatology, Division of Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
Loquai C; Department of Head and Neck Surgery, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Robert C; Department of Dermatology, University Medical Center Mainz, Mainz, Germany.
Baurain JF; Department of Dermatology, Institut Gustave Roussy and Paris-Saclay University, Villejuif, France.
Squittieri N; Department of Medical Oncology, Institut Roi Albert II, Cliniques universitaires Saint-Luc, UCLouvain, Brussels, Belgium.
Arntz R; Institute for Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium.
Dierlamm J; Medical Affairs Oncology, Sun Pharmaceutical Industries, Inc, Princeton, New Jersey.
Dréno B; Sun Pharmaceutical Industries, (Europe) B.V., Hoofddorp, North Holland, the Netherlands.

JAAD Int ; 10: 31-33, 2023 Mar.

Article em En | MEDLINE | ID: mdl-36425794

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Cuidados_paliativos / Geral Base de dados: MEDLINE Idioma: En Revista: JAAD Int Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google